Transcarotid Artery Revascularization (TCAR): A Modern Solution for Stroke Prevention

Transcarotid Artery Revascularization (TCAR) is a modern, minimally invasive procedure used to treat carotid artery disease, a condition caused by plaque buildup in the arteries supplying blood to the brain. This narrowing can significantly increase the risk of stroke, making timely treatment essential. TCAR has emerged as a safer and more effective alternative to traditional open surgery, especially for patients who are considered high-risk. This procedure combines surgical access with advanced stenting technology to restore proper blood flow. A key feature of TCAR is its innovative flow reversal system, which temporarily redirects blood away from the brain during the procedure. This allows any plaque debris to be safely filtered out, reducing the risk of stroke during treatment. TCAR is typically completed within 60 to 90 minutes. It involves a small incision near the collarbone, through which a catheter is inserted directly into the carotid artery. Blood flow is reversed and filtered before a stent is placed to open the blocked artery. Once the artery is secured, normal blood flow is restored, ensuring safety and effectiveness. One of the biggest advantages of TCAR is its suitability for high-risk patients, including older adults and those with heart or lung conditions or previous neck surgeries. Compared to traditional methods, it offers a smaller incision, lower complication risk, shorter hospital stays, and faster recovery. Most patients are discharged within 24 hours and can resume normal activities within a few days. With its minimally invasive approach and advanced safety mechanism, TCAR represents a significant advancement in stroke prevention.